Page last updated: 2024-08-25

4-phenylbutylamine and Diabetes Insipidus, Neurogenic

4-phenylbutylamine has been researched along with Diabetes Insipidus, Neurogenic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arima, H; Azuma, Y; Banno, R; Goto, M; Hagiwara, D; Ito, Y; Iwama, S; Miyata, T; Morishita, Y; Onoue, T; Suga, H; Takagi, H; Tochiya, M; Tsunekawa, T	1

Other Studies

1 other study(ies) available for 4-phenylbutylamine and Diabetes Insipidus, Neurogenic

Article	Year
Chemical chaperone 4-phenylbutylate reduces mutant protein accumulation in the endoplasmic reticulum of arginine vasopressin neurons in a mouse model for familial neurohypophysial diabetes insipidus. Neuroscience letters, 2018, 08-24, Volume: 682 Topics: Animals; Arginine Vasopressin; Butylamines; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons	2018

Article

Year

Chemical chaperone 4-phenylbutylate reduces mutant protein accumulation in the endoplasmic reticulum of arginine vasopressin neurons in a mouse model for familial neurohypophysial diabetes insipidus.

Neuroscience letters, 2018, 08-24, Volume: 682

Topics: Animals; Arginine Vasopressin; Butylamines; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum; Male; Mice; Mice, Inbred C57BL; Mutation; Neurons

2018